CAC Software vs AVIEW Lung Nodule CAD

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Coreline Soft Co.

AI Verdict

Tool A is a specialized solution dedicated to the automated detection and quantification of coronary artery calcification for cardiac risk assessment. Tool B offers a broader AI-powered platform primarily focused on pulmonary nodule detection and lung cancer screening, but also includes comprehensive coronary artery calcification scoring as part of its wider lung health assessment. Therefore, while both provide direct coronary artery calcification scoring, Tool A is a dedicated CAC tool, whereas Tool B integrates CAC into a more comprehensive pulmonary analysis.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary objective is a highly specialized and precise quantification of coronary artery calcification from non-contrast chest CTs. This tool is ideal for cardiologists and radiologists who need dedicated, deep-learning based analysis specifically for cardiovascular risk assessment and seamless integration into existing DICOM viewing workflows.

View CAC Software →

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if you require a comprehensive, multi-disease screening solution from a single chest CT scan. This software is best suited for radiologists seeking to simultaneously detect and analyze pulmonary nodules for lung cancer screening, quantify emphysema for COPD assessment, and score coronary artery calcification, providing a holistic view of thoracic health.

View AVIEW Lung Nodule CAD →

When choosing between Imbio’s CAC Software and Coreline Soft Co.’s AVIEW Lung Nodule CAD, physicians should consider their primary focus. Imbio’s CAC Software is specifically designed for detailed coronary artery calcification analysis, providing precise quantification of calcification, including Agatston score, arterial age, and calcified lesion mass and volume. It excels in offering 3D visualizations and annotated images, seamlessly integrating into existing DICOM viewing workflows for dedicated cardiac risk assessment from non-contrast chest CTs. This tool is ideal for cardiologists and radiologists whose main objective is a comprehensive evaluation of coronary artery disease risk.

In contrast, AVIEW Lung Nodule CAD offers a broader diagnostic scope, simultaneously analyzing lung nodules, emphysema, and coronary artery calcification (the “Big 3”). While it provides CAC scoring (Agatston, volume, mass scores), its key practical difference lies in its robust pulmonary nodule detection and analysis capabilities, including classification, 3D quantification, automatic Lung-RADS reporting, and volume doubling time calculations for follow-up. Therefore, AVIEW Lung Nodule CAD is better suited for radiologists and pulmonologists seeking a multi-faceted AI tool for comprehensive chest CT interpretation, particularly those involved in lung cancer screening and COPD assessment, who also desire integrated cardiac risk insights.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software AVIEW Lung Nodule CAD
Pricing Contact for pricing Contact for pricing
Deployment Cloud, On-premise, Partner platforms Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool A emphasizes a highly automated workflow, running automatically on input CT series with no user input or intervention and integrating seamlessly into existing DICOM viewing workflows. While Tool B offers automated reporting and classification, a study indicated it did not necessarily reduce interpretation time, suggesting a potentially less streamlined immediate user interaction despite its comprehensive features.

Clinical Value

AVIEW Lung Nodule CAD

Tool B offers significantly broader clinical value by providing a 'Big 3' simultaneous analysis of pulmonary nodules for lung cancer screening, emphysema for COPD, and coronary artery calcification from a single CT scan. Tool A, while effective, specializes solely in coronary artery calcification quantification.

Pricing & Value

Tie

Both tools require direct contact for pricing information, with no public disclosure of their pricing models. Without specific cost details, it is impossible to conduct a direct comparison of their value propositions.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA cleared and HIPAA compliant. They also offer flexible deployment options including cloud, on-premise, and hybrid solutions, catering to diverse institutional IT infrastructures. Tool A explicitly states the availability of a Business Associate Agreement (BAA), which is a critical component for healthcare enterprises.

Innovation

AVIEW Lung Nodule CAD

While both leverage AI, Tool B's 'Big 3' approach, enabling simultaneous analysis of lung nodules, emphysema, and coronary artery calcification from a single examination, represents a more significant innovation in integrated diagnostics and workflow efficiency. This multi-modal analysis from one scan pushes the boundaries further than Tool A's specialized CAC analysis.

Support & Docs

CAC Software

Imbio (Tool A) provides a clearly defined support structure, including phone numbers, email support, an online case submission form, and mentions the availability of user manuals and other product documentation upon request. Coreline Soft (Tool B) does not have similar explicit support information or readily accessible documentation detailed in the search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software AVIEW Lung Nodule CAD
Tool Name CAC Software AVIEW Lung Nodule CAD
Company Imbio Coreline Soft Co.
Primary Focus Automated image post-processing for coronary artery calcification from non-contrast chest CT. AI-powered assistance for detecting and analyzing pulmonary nodules, with additional screening for lung cancer, COPD, and coronary artery calcification.
Core Functionality for Coronary Artery Calcification (CAC) Automated image post-processing algorithms to determine location and calculate amount of calcification within coronary arteries. Coronary Artery Calcification (CAC) scoring.
CAC Output Metrics Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations and annotated images. Agatston, volume, mass scores.
Additional Analyses Offered None specified beyond CAC. AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D nodule size and volume quantification, automatic report generation (Lung-RADS), nodule matching and VDT calculation, quantitative emphysema analysis (LAA, emphysema index).
Specialties Supported Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CAC Software and AVIEW Lung Nodule CAD.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software is specifically designed for automated analysis and quantification of coronary artery calcification from non-contrast chest CTs to assess coronary artery disease risk. AVIEW Lung Nodule CAD offers a broader analysis, assisting with pulmonary nodule detection and analysis, comprehensive screening for lung cancer and COPD, and also includes coronary artery calcification scoring.
Both tools provide Agatston, volume, and mass scores for coronary artery calcification. Imbio's CAC Software additionally outputs arterial age and provides 3D visualizations and annotated images specifically for CAC. AVIEW Lung Nodule CAD integrates CAC scoring as part of its simultaneous analysis alongside lung nodules and emphysema.
No, Imbio's CAC Software is exclusively focused on the analysis and quantification of coronary artery calcification. AVIEW Lung Nodule CAD, however, provides extensive features for AI-based pulmonary nodule detection (3-20 mm), classification, 3D size and volume quantification, and automatic report generation based on Lung-RADS classification.
Imbio's CAC Software provides the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. AVIEW Lung Nodule CAD offers Agatston, volume, and mass scores for CAC as part of its multi-organ analysis.
Imbio's CAC Software is designed to help radiologists and cardiologists. AVIEW Lung Nodule CAD supports radiologists, pulmonologists, and cardiologists, reflecting its broader scope encompassing lung nodules, emphysema, and coronary artery calcification.
AVIEW Lung Nodule CAD provides AI-based pulmonary nodule detection, classification, 3D size and volume quantification, automatic report generation based on Lung-RADS, nodule matching, volume doubling time calculation, and quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index). Imbio's CAC Software focuses solely on coronary artery calcification.
AI Tool Finder
AI-powered search. Results may not be comprehensive.